Deferred Tax Assets, Operating Loss Carryforwards of IMMUCELL CORP /DE/ from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
IMMUCELL CORP /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • IMMUCELL CORP /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $3,705,923, a 0.63% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,705,923 -$23,577 -0.63% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $3,729,500 +$471,105 +14% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $3,258,395 +$164,112 +5.3% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $3,094,283 +$19,401 +0.63% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $3,074,882 +$565,411 +23% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $2,509,471 +$23,208 +0.93% 31 Dec 2019 10-K 27 Mar 2020 2019 FY
Q4 2018 $2,486,263 +$2,126,499 +591% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $359,764 31 Dec 2017 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.